Bill Text: NJ A2203 | 2022-2023 | Regular Session | Introduced

---

Bill Title: Provides sales and use tax exemption for purchases of rapid or laboratory tests for purposes of detecting infections.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2022-02-07 - Introduced, Referred to Assembly Health Committee [A2203 Detail]

Download: New_Jersey-2022-A2203-Introduced.html

---

ASSEMBLY, No. 2203

STATE OF NEW JERSEY

220th LEGISLATURE

 

INTRODUCED FEBRUARY 7, 2022

 

 

Sponsored by:

Assemblyman  ERIK PETERSON

District 23 (Hunterdon, Somerset and Warren)

 

 

 

 

SYNOPSIS

     Provides sales and use tax exemption for purchases of rapid or laboratory tests for purposes of detecting infections.

 

CURRENT VERSION OF TEXT

     As introduced.

  

An Act providing a sales and use tax exemption for sales of certain viral tests or antibody tests for purposes of detecting infections, supplementing P.L.1966, c.30 (C.54:32B-1 et seq.).

 

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

     1.    Receipts from sales of rapid or laboratory viral tests or antibody tests, including, but not limited to, molecular and antigen tests, utilized for the purpose of detecting infections, such as SARS-CoV-2, are exempt from the tax imposed under the "Sales and Use Tax Act," P.L.1966, c.30 (C.54:32B-1 et seq.).

 

     2.    This act shall take effect immediately and apply to sales occurring on or after the first day of the second month next following enactment.

 

 

STATEMENT

 

     This bill exempts from New Jersey sales and use tax purchases of rapid or laboratory viral tests or antibody tests.  The exemption will apply, but not be limited to, molecular and antigen tests utilized for detecting infections, such as SARS-CoV-2.